Esposito S, Leone S, Noviello S, Ianniello F, Fiore M, Russo M, Foti G, Carpentieri MS, Cellesi C, Zanelli G, Cellini A, Girmenia C, De Lalla F, Maiello A, Maio P, Marranconi F, Sabbatani S, Pantaleoni M, Ghinelli F, Soranzo ML, Vigano P, Re T, Viale P, Scudeller L, Scaglione F, Vullo V. Outpatient parenteral antibiotic therapy for bone and joint infections: an Italian multicenter study. J Chemother. 2007;19(4):417–22. https://doi.org/10.1179/joc.2007.19.4.417.
Article CAS PubMed Google Scholar
Yadav K, Suh KN, Eagles D, Thiruganasambandamoorthy V, Wells GA, Stiell IG. Evaluation of an emergency department to outpatient parenteral antibiotic therapy program for cellulitis. Am J Emerg Med. 2019;37(11):2008–14. https://doi.org/10.1016/j.ajem.2019.02.023.
• Staples JA, Ho M, Ferris D, Hayek J, Liu G, Tran KC, Sutherland JM. Outpatient versus inpatient intravenous antimicrobial therapy: a population-based observational cohort study of adverse events and costs. Clin Infect Dis. 2022;75(11):1921–9. https://doi.org/10.1093/cid/ciac298. This article compares OPAT to inpatient parenteral antibiotics which suggests that expanding OPAT programs could be beneficial.
• Mitchell SG, Nordeck CD, Lertch E, Ross TE, Welsh C, Schwartz RP, Gryczynski J. Patients with substance use disorders receiving continued care in skilled nursing facilities following hospitalization. Subst Abus. 2022;43(1):848–54. https://doi.org/10.1080/08897077.2021.2007512. This study investigates the experiences of patients who inject drugs that were transferred from hospitals to SNFs, noting that SNFs present challenges when it comes to treatment and access to substance-use services.
Article PubMed PubMed Central Google Scholar
Lee YL, Thrupp LD, Lee R, Nothvogel S, Farsad N, Cesario T. Infection surveillance and antibiotic utilization in a community-based skilled nursing facility. Aging (Milano). 1996;8(2):113–22. https://doi.org/10.1007/BF03339565.
Article CAS PubMed Google Scholar
Wang L, Lansing B, Symons K, Flannery EL, Fisch J, Cherian K, McNamara SE, Mody L. Infection rate and colonization with antibiotic-resistant organisms in skilled nursing facility residents with indwelling devices. Eur J Clin Microbiol Infect Dis. 2012;31(8):1797–804. https://doi.org/10.1007/s10096-011-1504-7. Epub 2012 Jan 25.
Article CAS PubMed PubMed Central Google Scholar
Rogers MA, Mody L, Chenoweth C, Kaufman SR, Saint S. Incidence of antibiotic-resistant infection in long-term residents of skilled nursing facilities. Am J Infect Control. 2008;36(7):472–5. https://doi.org/10.1016/j.ajic.2007.10.016.
Article PubMed PubMed Central Google Scholar
• Hurley H, Sikka M, Jenkins T, Cari EV, Thornton A. Outpatient antimicrobial treatment for people who inject drugs. Infect Dis Clin North Am. 2020;34(3):525–38. https://doi.org/10.1016/j.idc.2020.06.009. This article discusses the increasing incidence of serious bacterial infections among PWID and the challenges they face in completing prolonged courses. It identifies a need for innovations in treatments and care models that address barriers to treatment completion.
D'Couto HT, Robbins GK, Ard KL, Wakeman SE, Alves J, Nelson SB. Outcomes according to discharge location for persons who inject drugs receiving outpatient parenteral antimicrobial therapy. Open Forum Infect Dis. 2018 Apr 18;5(5):ofy056. https://doi.org/10.1093/ofid/ofy056.
Bork JT, Heil EL, Berry S, Lopes E, Davé R, Gilliam BL, Amoroso A. Dalbavancin use in vulnerable patients receiving outpatient parenteral antibiotic therapy for invasive gram-positive infections. Infect Dis Ther. 2019;8(2):171–84. https://doi.org/10.1007/s40121-019-0247-0. Epub 2019 May 3.
Article PubMed PubMed Central Google Scholar
Coyle JR, Freeland M, Eckel ST, Hart AL. Trends in morbidity, mortality, and cost of hospitalizations associated with infectious disease sequelae of the opioid epidemic. J Infect Dis. 2020;222(Suppl 5):S451–7. https://doi.org/10.1093/infdis/jiaa012.
Bryson-Cahn C, Beieler AM, Chan JD, Harrington RD, Dhanireddy S. Dalbavancin as secondary therapy for serious staphylococcus aureus infections in a vulnerable patient population. Open Forum Infect Dis. 2019 Jan 30;6(2):ofz028. https://doi.org/10.1093/ofid/ofz028.
Morrisette T, Miller MA, Montague BT, Barber GR, McQueen RB, Krsak M. Long-acting lipoglycopeptides: “lineless antibiotics” for serious infections in persons who use drugs. Open Forum Infect Dis. 2019 Jun 5;6(7):ofz274. https://doi.org/10.1093/ofid/ofz274.
Buehrle DJ, Shields RK, Shah N, Shoff C, Sheridan K. Risk factors associated with outpatient parenteral antibiotic therapy program failure among intravenous drug users. Open Forum Infect Dis. 2017 May 23;4(3):ofx102. https://doi.org/10.1093/ofid/ofx102.
Ho J, Archuleta S, Sulaiman Z, Fisher D. Safe and successful treatment of intravenous drug users with a peripherally inserted central catheter in an outpatient parenteral antibiotic treatment service. J Antimicrob Chemother. 2010;65(12):2641–4. https://doi.org/10.1093/jac/dkq355.
Article CAS PubMed Google Scholar
Camsari UM, Libertin CR. Small-town America’s despair: infected substance users needing outpatient parenteral therapy and risk stratification. Cureus. 2017;9(8): e1579. https://doi.org/10.7759/cureus.1579.
Article PubMed PubMed Central Google Scholar
Cortes-Penfield N, Cawcutt K, Alexander BT, Karre VMM, Balasanova AA. A proposal for addiction and infectious diseases specialist collaboration to improve care for patients with opioid use disorder and injection drug use-associated infective endocarditis. J Addict Med. 2022 Jul-Aug 01;16(4):392–395. https://doi.org/10.1097/ADM.0000000000000936.
Ronan MV, Herzig SJ. Hospitalizations related to opioid abuse/dependence and associated serious infections increased sharply, 2002–12. Health Aff (Millwood). 2016;35(5):832–7. https://doi.org/10.1377/hlthaff.2015.1424.
Norris AH, Shrestha NK, Allison GM, Keller SC, Bhavan KP, Zurlo JJ, Hersh AL, Gorski LA, Bosso JA, Rathore MH, Arrieta A, Petrak RM, Shah A, Brown RB, Knight SL, Umscheid CA. 2018 Infectious Diseases Society of America clinical practice guideline for the management of outpatient parenteral antimicrobial therapy. Clin Infect Dis. 2019;68(1):e1–35. https://doi.org/10.1093/cid/ciy745.
Foley OW, Ferris TG, Thompson RW, Heng M, Ricciardi R, Del Carmen MG, Safavi KC. Potential impact of hospital at home on postoperative readmissions. Am J Manag Care. 2021;27(12):e420–5. https://doi.org/10.37765/ajmc.2021.88797.
Leff B, Burton L, Guido S, Greenough WB, Steinwachs D, Burton JR. Home hospital program: a pilot study. J Am Geriatr Soc. 1999;47(6):697–702. https://doi.org/10.1111/j.1532-5415.1999.tb01592.x.
Article CAS PubMed Google Scholar
Leff B, Burton L, Mader SL, Naughton B, Burl J, Inouye SK, Greenough WB 3rd, Guido S, Langston C, Frick KD, Steinwachs D, Burton JR. Hospital at home: feasibility and outcomes of a program to provide hospital-level care at home for acutely ill older patients. Ann Intern Med. 2005;143(11):798–808. https://doi.org/10.7326/0003-4819-143-11-200512060-00008.
Levine DM, Ouchi K, Blanchfield B, Saenz A, Burke K, Paz M, Diamond K, Pu CT, Schnipper JL. Hospital-level care at home for acutely ill adults: a randomized controlled trial. Ann Intern Med. 2020;172(2):77–85. https://doi.org/10.7326/M19-0600.
Anthony M. Hospital-at-home. Home Healthc Now. 2021 May-Jun 01;39(3):127. https://doi.org/10.1097/NHH.0000000000000984.
Patel HY, West DJ Jr. Hospital at home: an evolving model for comprehensive healthcare. Glob J Qual Saf Healthc. 2021;4(4):141–6. https://doi.org/10.36401/JQSH-21-4.
Article PubMed PubMed Central Google Scholar
• Leong MQ, Lim CW, Lai YF. Comparison of hospital-at-home models: a systematic review of reviews. BMJ Open. 2021;11(1): e043285. https://doi.org/10.1136/bmjopen-2020-043285. (This systematic review on hospital-at-home (HaH) programs compares early-discharge and admission-avoidance models. HaH is generally seen to produce similar or even improved outcomes for patients than hospital care.)
Article PubMed PubMed Central Google Scholar
Shepperd S, Iliffe S, Doll HA, Clarke MJ, Kalra L, Wilson AD, Gonçalves-Bradley DC. Admission avoidance hospital at home. Cochrane Database Syst Rev. 2016 Sep 1;9(9):CD007491. https://doi.org/10.1002/14651858.CD007491.pub2.
Varney J, Weiland TJ, Jelinek G. Efficacy of hospital in the home services providing care for patients admitted from emergency departments: an integrative review. Int J Evid Based Healthc. 2014;12(2):128–41. https://doi.org/10.1097/XEB.0000000000000011.
Jeppesen E, Brurberg KG, Vist GE, Wedzicha JA, Wright JJ, Greenstone M, Walters JA. Hospital at home for acute exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2012 May 16;(5):CD003573. https://doi.org/10.1002/14651858.CD003573.pub2.
McMahon JH, O'keeffe JM. Victorian Hith Outcomes Study Group; Grayson ML. Is hospital-in-the-home (HITH) treatment of bacterial endocarditis safe and effective? Scand J Infect Dis. 2008;40(1):40–3. doi: https://doi.org/10.1080/00365540701522942.
Pajarón M, Lisa M, Fernández-Miera MF, Dueñas JC, Allende I, Arnaiz AM, Sanroma-Mendizábal P, De Berrazueta JR, Fariñas MC. The Hospital Marqués de Valdecilla Endocarditis Study Group.*. Efficiency of a self-administered outpatient parenteral antimicrobial therapy (s-opat) for infective endocarditis within the context of a shortened hospital admission based on hospital at home program. Hosp Pract (1995). 2017 Dec;45(5):246–252. https://doi.org/10.1080/21548331.2017.1398588.
Keren R, Shah SS, Srivastava R, Rangel S, Bendel-Stenzel M, Harik N, Hartley J, Lopez M, Seguias L, Tieder J, Bryan M, Gong W, Hall M, Localio R, Luan X, deBerardinis R, Parker A. Pediatric Research in Inpatient Settings Network. Comparative effectiveness of intravenous vs oral antibiotics for postdischarge treatment of acute osteomyelitis in children. JAMA Pediatr. 2015 Feb;169(2):120–8. https://doi.org/10.1001/jamapediatrics.2014.2822.
Zaoutis T, Localio AR, Leckerman K, Saddlemire S, Bertoch D, Keren R. Prolonged intravenous therapy versus early transition to oral antimicrobial therapy for acute osteomyelitis in children. Pediatrics. 2009;123(2):636–42. https://doi.org/10.1542/peds.2008-0596.
Rangel SJ, Anderson BR, Srivastava R, Shah SS, Ishimine P, Srinivasan M, Bryan M, Gong W, Hall M, Localio R, Luan X, Anandalwar S, Keren R. Pediatric Research in Inpatient Settings (PRIS) Network. Intravenous versus oral antibiotics for the prevention of treatment failure in children with complicated appendicitis: has the abandonment of peripherally inserted catheters been justified? Ann Surg. 2017 Aug;266(2):361–368. https://doi.org/10.1097/SLA.0000000000001923.
Stockmann C, Ampofo K, Pavia AT, Byington CL, Sheng X, Greene TH, Korgenski EK, Hersh AL. Comparative effectiveness of oral versus outpatient parenteral antibiotic therapy for empyema. Hosp Pediatr. 2015;5(12):605–12. https://doi.org/10.1542/hpeds.2015-0100.
Shah SS, Srivastava R, Wu S, Colvin JD, Williams DJ, Rangel SJ, Samady W, Rao S, Miller C, Cross C, Clohessy C, Hall M, Localio R, Bryan M, Wu G, Keren R. Pediatric Research in Inpatient Settings Network. Intravenous versus oral antibiotics for postdischarge treatment of complicated pneumonia. Pediatrics. 2016 Dec;138(6):e20161692. https://doi.org/10.1542/peds.2016-1692.
• Kimmel SD, Kim JH, Kalesan B, Samet JH, Walley AY, Larochelle MR. Against medical advice discharges in injection and non-injection drug use-associated infective endocarditis: a nationwide cohort study. Clin Infect Dis. 2021;73(9):e2484–92. https://doi.org/10.1093/cid/ciaa1126. This article discusses self-directed discharge among PWID with infective endocarditis in the USA from 2010 to 2015, highlighting the need to reduce self-directed discharges in this population.
Kimmel SD, Rosenmoss S, Bearnot B, Larochelle M, Walley AY. Rejection of patients with opioid use disorder referred for post-acute medical care before and after an anti-discrimination settlement in Massachusetts. J Addict Med. 2021 Jan-Feb 01;15(1):20–26. https://doi.org/10.1097/ADM.0000000000000693.
Miller AC, Polgreen PM. Many opportunities to record, diagnose, or treat injection drug-related infections are missed: a population-based cohort study of inpatient and emergency department settings. Clin Infect Dis. 2019;68(7):1166–75. https://doi.org/10.1093/cid/ciy632.
Kouijzer IJE, van Leerdam EJ, Gompelman M, Tuinte RAM, Aarntzen EHJG, Berrevoets MAH, Maat I, Bleeker-Rovers CP, van Crevel R, Ten Oever J. Intravenous to oral switch in complicated staphylococcus aureus bacteremia without endovascular infection: a retrospective single-center cohort study. Clin Infect Dis. 2021;73(5):895–8. https://doi.org/10.1093/cid/ciab156.
Article CAS PubMed PubMed Central Google Scholar
• Juskowich JJ, Ward A, Spigelmyer AE, Howard CA, Slain D, Guilfoose JA, Edmond MB, Sarwari AR. Complex outpatient antimicrobial therapy (COpAT) program at a rural academic medical center: evaluation of first 100 patients. Open Forum Infect Dis. 2022;9(Issue Supplement_2):ofac492.843. https://doi.org/10.1093/ofid/ofac492.843. This paper talks about the complex outpatient antimicrobial therapy (COpAT) program, which uses oral antibiotics, as an alternative to prolonged IV antibiotics. COpAT safely reduced hospital length of stay and bed shortages during the COVID-19 pandemic, leading to cost savings while maintaining satisfactory clinical outcomes, particularly among patients PWID.
Keller SC, Ciuffetelli D, Bilker W, Norris A, Timko D, Rosen A, Myers JS, Hines J, Metlay J. The impact of an infectious diseases transition service on the care of outpatients on parenteral antimicrobial therapy. J Pharm Technol. 2013;29(5):205–14. https://doi.org/10.1177/8755122513500922.
留言 (0)